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From the Editor’s Desk
THE ABSENCE OF MANY 
VOICES IN PROTEST
Australian medicine faces a life-threatening 
disease in the form of an unprecedented 
grab for control by governments. Its latest 
symptom is the potential hijacking of the 
profession’s control over self-regulation and 
education. These are slated to become the 
responsibilities of committees in which 
doctors will have less influence. The extent 
of the hijack will become clearer when the 
Council of Australian Governments 
establishes a national body to register and 
set competency standards for doctors and 
other health professionals, and a national 
accreditation body to establish standards 
for their education. With these 
developments, what will be the fate of 
medical boards, medical colleges and the 
Australian Medical Council?
This grab for control is a worldwide 
phenomenon, as “the regulation of the 
medical profession is subjected to 
unprecedented, and growing, public debate, 
increasing intervention in the daily 
professional activities of physicians, and 
increasing oversight by the central state”.* 
A recent World Medical Association press 
release warned that the WMA’s Secretary 
General believed that “.. .by steady steps, 
governments were taking away degrees of 
freedom from the profession’s self governing 
bodies. ‘And this is not a cosmetic change —
it means democratic participation is being 
dismantled. We’ve seen it across Europe, 
we’ve seen it in New Zealand, in Hong Kong 
and elsewhere,’ he said. ‘This is something 
that is going on very silently, with small steps 
in many countries’”. And he may well have 
added we are seeing it in Australia. 
But where are the many voices in protest? 
There seems to be little in the way of 
overwhelming public response to 
Australian medicine’s life-threatening 
disease. Could it be that doctors support 
the reforms, or have become fatigued by 
their never ending tussles with 
governments to maintain self-governance? 
The absence of many voices in public 
protest may well seal the fate of the 
profession’s independence.
Martin B Van Der Weyden
*Moran M. The British regulatory state: 
high modernism and hyper-innovation. 
Oxford: Oxford University Press, 2003.
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Letters
Organ donation from prison
Elizabeth Magee and Michael H Levy
TO THE EDITOR: The National Health and
Medical Research Council’s National state-
ment on ethical conduct in research involving
humans1 recognises that prisoners can par-
ticipate in research, but categorises them as
“persons in dependent or unequal relation-
ships”. They have limited capacity to pro-
vide informed consent.
Responding to the high levels of transmis-
sion of bloodborne viruses in Australian
prisons,2 the Australian Red Cross Blood
Service excludes prisoners from donating
blood and ex-prisoners are excluded for 12
months after they have been released from
prison.3
The New South Wales Human Tissue Act
1983 is silent on whether prisoners can
donate organs.
We report here the case of a prisoner
organ donor, highlighting the administra-
tive, legal and operational hurdles that
needed to be overcome.
A 53-year-old male prisoner was a suit-
able living kidney donor for his first cousin.
He provided consent willingly and without
coercion.
At initial assessment, the prisoner’s classi-
fication required that he be escorted to
hospital and that constant surveillance by
prison officers be maintained — at a cost of
$1000 per day, for at least 7 days. These
costs would have been borne by the family.
Furthermore, as Australian prisoners are
ineligible for Medicare under the Australian
Constitution, the donor, as an uninsured
patient, and his family would have been
required to pay for all pre-, peri- and post-
operative care.
The donation was deferred for 14 months
while these two administrative hurdles were
overcome to permit the donation to pro-
ceed:
1. The Commissioner for the Department
of Corrective Services gave approval for the
prisoner to be reclassified to the lowest
security classification, thus removing the
need for surveillance while in hospital; and
2. A rarely used provision within the
NSW Crimes (Administration of Sentences) Act
1999 was applied. Section 26(1) of the Act
allows the Commissioner to issue a permit
allowing an inmate to be absent from a
correctional centre: (a) on such condi-
tions and for such period as may be
specified in the permit, and (b) for such
purpose as the Commissioner considers
appropriate.
This allowed the prisoner to be temporar-
ily reinstated to receive Medicare entitle-
ments.
The nephrectomy and transplantation
were successfully performed. The donor
returned to prison on the seventh postoper-
ative day. The donor organ is functioning 4
months after the operation.
Prisoners have a right to participate in
organ donor programs; however, their pre-
carious position to provide informed con-
sent needs to be protected.
Elizabeth Magee, Nurse Unit Manager
Michael H Levy, Director, Centre for Health 
Research in Criminal Justice
Justice Health, Sydney, NSW.
michael.levy@justicehealth.nsw.gov.au
1 National Health and Medical Research Council.
National statement on ethical conduct in research
involving humans. Canberra: NHMRC, 1999. http://
www.nh mrc.gov.au/publ icat ions /syno pses/
e35syn.htm (accessed Nov 2006).
2 Butler T, Kariminia A, Levy M, Kaldor J. Prisoners are
at risk for hepatitis C transmission. Eur J Epidemiol
2004; 19: 1119-1122.
3 Australian Red Cross Blood Service. Confidential
donor  ques tionn aire. ht tp :/ /www.donate -
blood.com.au/Donor/guide/eligible.asp (accessed
Nov 2006). ❏
Registering wishes about 
organ donation may decrease 
the number of donors
Mitchell Lawlor and Frank A Billson
TO THE EDITOR: An important factor in
the well documented shortfall of organs and
eyes for transplantation is the apparent
reluctance of people to agree to donate.1
One nearly universal strategy in attempting
to raise donation rates has been to encour-
age individuals to register their wishes about
donation. Although evidence that this strat-
egy increases donation rates is lacking, there
is some evidence that more individuals
make and communicate a decision with
appropriate education.2
Most families consent to donation when
the deceased had indicated this was their
wish, and virtually none override a stated
wish not to donate.3 When wishes are
unknown, half of families consent and half
refuse.3 Encouraging declaration of inten-
tion aims to increase the rate of consent for
families who would otherwise not know the
deceased individual’s wishes. For this to be
successful, most individuals newly record-
ing their wishes must indicate a desire to
donate. This assumption has underpinned
Australian education campaigns, including
“Talk about it”, “Share your life, share your
decision”, and most recently the national
“Sign on to save a life” campaign.4
A simple review of New South Wales
Roads and Traffic Authority organ donation
data over the period of these campaigns
suggests this assumption may not hold.
From 1997 to 2004, a significant proportion
of drivers licence holders newly indicated a
preference about donation; the proportion
indicating some decision rose from 59.4% to
78.6%. Over the same period, the propor-
tion indicating yes to donation of all organs
rose from 35.6% to 41.9% (a 17.7%
increase); however, the proportion indicat-
ing no to any donation rose from 19.9% to
31.4% (a 57.8% increase).5
These results raise the possibility that
encouraging individuals to make a decision
about donation may increase the number of
families who refuse donation. Individuals
who had previously not made a decision
about donation, when encouraged to do so,
displayed an unwillingness to become organ
donors at twice the rate of those who indi-
cated willingness. Although it is imperative
to recognise and respect the decision of
individuals to refuse organ donation, this
unwillingness may reflect either formalisa-
tion of a considered desire not to donate, or
a decision made without personal discus-
sion of fears and concerns about donation.
Generalised education campaigns are lim-
ited in that they encourage action without
addressing fears and concerns. Further pol-
icy should recognise a possible danger in
simply exhorting the public to make a deci-
sion, and research should investigate why
individuals are refusing to become organ
and eye donors.
Mitchell Lawlor, Ophthalmology Registrar
Frank A Billson, Director
Save Sight Institute, Sydney, NSW.
mitchell@eye.usyd.edu.au
1 Siminoff LA, Gordon N, Hewlett J, et al. Factors
influencing families’ consent for donation of solid
organs for transplantation. JAMA 2001; 286: 71-77.
2 Sanner MA, Hedman H, Tufveson G. Evaluation of
an organ-donor-card campaign in Sweden. Clin
Transplant 1995; 9: 326-333.
3 Siminoff LA, Lawrence RH. Knowing patients’ pref-
erences about organ donation: does it make a
difference? J Trauma 2002; 53: 754-760.
4 Medicare Australia. Australian organ donor register.
http://www.medicareaustralia.gov.au/yourhealth/
our_services/aaodr.htm (accessed Dec 2006).
5 New South Wales Roads and Traffic Authority. Reg-
istration and l icens ing stat istics.  ht tp :/ /
www.rta.nsw.gov.au/publicationsstatisticsforms/
downloads/statiregis_dl6.html?plid=33 (accessed
Dec 2006). ❏156 MJA • Volume 186 Number 3 • 5 February 2007
LETTERSPotential for organ donation 
in Victoria: an audit of 
hospital deaths
Deepak Bhonagiri and Patricia Wills
TO THE EDITOR: Opdam and Silvester
concluded that the small pool of organ
donors limits the potential for organ dona-
tion in Victoria.1
According to the definition of death in the
Human Tissue Act 1983 (NSW):
a person has died when there has
occurred: (a) irreversible cessation of all
function of the person’s brain, or (b)
irreversible cessation of circulation of
blood in the person’s body.
Current cadaveric organ donation takes
place predominantly after brain death,
although it is also possible after cardiac
death. This was previously described as
“non-heart-beating organ donation”, but the
name was changed to “donation after car-
diac death” (DCD) to emphasise that organ
donation occurs only after death.
DCD can be classified by the Maastricht
criteria (Box).2 Category III is relevant in
select patients undergoing planned with-
drawal of therapy in intensive care units
(ICUs). Planned withdrawal of therapy is
said to occur in about 60% of all ICU
deaths.3
Permission for organ donation is required
before the planned withdrawal of life sup-
port, so the donor organ retrieval teams can
be available and ready to retrieve organs
soon after a 5-minute “cooling off” period
after circulation ceases. These 5 minutes also
allow families to spend time with the
deceased after death. A period of less than
60 minutes between withdrawal of therapy
and cessation of circulation is recommended
to minimise warm ischaemia time in the
retrieved organs. Withdrawal of life support
may occur in the ICU or in the operating
room complex, and local hospital guidelines
should address the issue of where this
occurs.
Between 1989 and 2004, 30 Australian
organ donations involved non-heart-beating
organ donors (data from the Australia New
Zealand Organ Donor Registry). In 2005,
eight New South Wales organ donations,
accounting for 14% of all cadaveric renal
transplantation, proceeded after cardiac
death criteria were applied. In our unpub-
lished retrospective audit, 7% of patients
who had planned withdrawal of therapy in
the ICU met the criteria for eligible organ
donors after cardiac death. The organ donor
pool for organ donation after brain death
was 1.7% in Opdam and Silvester’s study.1
The long-term function of transplanted
kidneys is not significantly different for
organs retrieved after cardiac death com-
pared with organs retrieved after brain
death.4 Liver and lung transplantation are
also possible from organs retrieved from
non-heart-beating organ donors.
Draft guidelines for DCD in NSW are
soon to be released by NSW Health. Similar
guidelines in other states and education of
staff involved in organ donation would no
doubt increase the organ donation pool and
the potential for organ donation.
Deepak Bhonagiri, Medical Consultant
Patricia Wills, Manager
LifeLink Organ and Tissue Donation Network, 
Australian Red Cross Blood Service, Sydney, 
NSW.
deepak@unsw.edu.au
1 Opdam HI, Silvester W. Potential for organ dona-
tion in Victoria: an audit of hospital deaths. Med J
Aust 2006; 185: 250-254. 
2 Kootstra G, Daemen JH, Oomen AP. Categories of
non-heart-beating donors. Transplant Proc 1995;
27: 2893-2894.
3 Cook D, Rocker G, Marshall J, et al; Level of Care
Study Investigators and the Canadian Critical Care
Trials Group. Withdrawal of mechanical ventilation
in anticipation of death in the intensive care unit.
N Engl J Med 2003; 349: 1123-1132.
4 Weber M, Dindo D, Demartines N, et al. Kidney
transplantation from donors without a heartbeat.
N Engl J Med 2002; 347: 248-255. ❏
Suicide mortality data 
need revision
Diego De Leo
TO THE EDITOR: In 2004, there were 580
cases of suicide in Queensland, and not 453,
as reported by the Australian Bureau of Statis-
tics (ABS) on 14 March 2006.1 These data
alone reverse the declining trend for suicide
mortality nationally in the most recent years.
The Queensland Suicide Register, maintained
by the Australian Institute for Suicide
Research and Prevention (AISRAP), receives
data directly from the Office of the State
Coroner, and crosschecks them with other
Queensland coroners, the John Tonge Centre
(the Queensland Health Scientific Services
mortuary), and the National Coroners Infor-
mation System (NCIS). The ABS receives data
from the state registries of births, deaths and
marriages, and crosschecks them with the
state coroners’ offices. The agreement
between the two agencies has been decreas-
ing in recent years, with AISRAP detecting
550 suicide cases in 2003 and 588 in 2002,
compared with 466 and 537, respectively,
detected by the ABS (Box).
The ABS has acknowledged difficulties in
getting reliable data for 2004 in a number of
endnotes to its yearly report.1 Most of the
problems were related to a very large back-
log of cases still under investigation by
coroners, a phenomenon that is reported as
increasing in recent years. A confirmation of
problems in official data comes from the
NCIS, whose most recent report has evi-
denced, from 2000 on, declining percent-
ages of completeness in mortality data in
Queensland and elsewhere in Australia,
with the most incomplete figures in 2004.2
It is important to note that cases that are
under investigation and those that end with
Number of suicides in Queensland according to the Australian Bureau of 
Statistics and the Queensland Suicide Register (QSR)
QSR data were provided by the Office of the State Coroner, the National Coroners Information System and 
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suicide mortality data, as these are never
reconciled. Following the example of many
European countries, it would be desirable to
start a periodical publication (eg, every 3–5
years) to provide a more comprehensive
picture of suicide mortality, including final-
ised investigations, reclassified (ex-acciden-
tal or ex-undetermined) causes of deaths,
and deaths that occurred (especially in hos-
pitals) with a delay from a self-injurious
event. This would provide a more credible
depiction of suicide mortality in the country,
and permit better research.3
Meanwhile, efforts should be made to
homogenise certification procedures (Inter-
national classification of diseases, 10th revi-
sion terminology has yet to be extensively
adopted) and streamline the bureaucratic
procedures (we still suffer from a number of
“lost in the system” data). In the registries of
births, deaths and marriages, by law, the
word “suicide” (or analogous term) does not
appear. Frequently, the ABS, which collects
data from the registries each month, has to
reclassify the data obtained, and integrate
the information received with further
enquiries. Apart from being time-consum-
ing, this routine does not provide foolproof
results, and has potential for improvement.
Some underreporting in suicide statistics
is virtually ubiquitous,3,4 and has to be
tolerated (eg, misclassification as accident,
road accident, or disease-related, particu-
larly in the elderly; cover-up because of
stigma, sociocultural norms, or insurance
reasons; or remoteness of location). How-
ever, federal and state governments in Aus-
tralia are committed to suicide prevention
plans that require credible baselines for eval-
uating their effects. All relevant parties need
to work jointly on improving data quality.
This is of crucial importance for scientists
and policymakers, and for those personally
affected by a suicide death.
Acknowledgements: Thanks are due to Tara Pritch-
ard (ABS), Jessica Pearse (NCIS), Michael Barnes
(QLD State Coroner), Gill Aspinall (QLD Police),
Charles Naylor (John Tonge Centre), and Helen
Klieve, Allison Millner, Dominique Murray and Mar-
ianne Wyder (AISRAP).
Diego De Leo, Director and Professor of 
Psychiatry
Australian Institute for Suicide Research and 
Prevention, Griffith University, Brisbane, QLD.
d.deleo@griffith.edu.au
1 Australian Bureau of Statistics. Suicides, Australia,
1994–2004. Canberra: ABS, 2006. (ABS Catalogue
No. 3309.0.)
2 National Coroners Information System. Annual
Report 2006. Melbourne: NCIS, Monash University,
2006.
3 De Leo D, Bertolote JM, Lester D. Self-directed
violence. In: Krug E, Dalhberg L, Mercy J, et al,
editors. World report on violence and health.
Geneva: WHO, 2002: 183-212.
4 Andriessen K. Do we need to be cautious in evalu-
ating suicide statistics? Eur J Public Health 2006; 16:
445-447. ❏
An unusual cause of severe 
metabolic acidosis
Mark A Boyd and Stephen Hedger
TO THE EDITOR: We read with interest the
“Diagnostic Dilemma” by Peter et al.1 The
case raises interesting management issues.
The first is initiation of antibiotics. Despite 1
week of fever, rigors, haematuria and loin
pain, we are informed that the patient was in
no distress at initial assessment. In this situa-
tion there is, despite the anxieties of resident
staff, no urgent need to administer antibiot-
ics; hospitals are controlled, monitored envi-
ronments in which observation, review and
investigation can be undertaken, within rea-
son, if a diagnosis is not immediately made.
The second issue is antibiotic selection. The
provisional diagnosis was a urinary tract
infection, and ceftriaxone and gentamicin
were administered. The justification for the
use of two agents with a similar spectrum of
antimicrobial activity is not given.2 Likewise,
no justification is given for the use of a potent
nephrotoxin in the presence of moderately
severe acute renal failure.
Flucloxacillin was added “to broaden the
gram-positive antibiotic cover”. It is not
apparent why staphylococcal cover was
sought at this stage. All cultures (blood, urine
and pleural fluid) remained negative. At Day
14, ceftriaxone and gentamicin were changed
to ticarcillin/clavulanic acid and ciprofloxacin
“because of persistent fever and rising [white
cell count]”; this decision in the absence of
positive cultures is not explained.
The patient’s renal function deteriorated
further and he became profoundly acidotic.
In fact, the patient’s renal function had
performed heroically, given administration
of gentamicin for 2 weeks in the presence of
acute renal failure at admission. In the
intensive care unit, flucloxacillin was
replaced with vancomycin; the rationale is
not explained.
This case illustrates important points
regarding antibiotic use. Despite significant
renal impairment at admission, the patient
was administered a 2-week course of a neph-
rotoxic antibiotic, which contributed to renal
collapse. This situation would have been
terminal if not for supportive intensive care.
The treating team appears to have managed
the patient as if sepsis were a given, and yet
all cultures remained negative. This illustrates
a basic but crucial teaching point — fevers,
chills, rigors, raised inflammatory markers
and neutrophilia do not necessarily equate
with sepsis. If this experience reflects routine
practice elsewhere (and it is our experience
that it does), is it any wonder that we have
reached an era in which we now encounter
organisms so resistant that they are essentially
untreatable?3
Mark A Boyd, Infectious Diseases Physician
Stephen Hedger, General Physician
Flinders Medical Centre, Adelaide, SA.
mark.boyd@fmc.sa.gov.au
1 Peter JV, Rogers N, Murty S, et al. An unusual cause
of severe metabolic acidosis. Med J Aust 2006; 185:
223-225. 
2 Safdar N, Handelsman J, Maki DG. Does combina-
tion antimicrobial therapy reduce mortality in
Gram-negative bacteraemia? A meta-analysis. Lan-
cet Infect Dis 2004; 4: 519-527.
3 Peleg AY, Paterson DL. Multidrug-resistant Acineto-
bacter: a threat to the antibiotic era. Intern Med J
2006; 36: 479-482. ❏
John V Peter, Natasha Rogers and 
Sandra L Peake
IN REPLY: Boyd and Hedger have raised
concerns regarding the initiation and choice
of antibiotics in our recent case report.1
Several aspects of this correspondence need
to be addressed. The primary focus of the
article was to highlight an important and
probably underrecognised cause of unex-
plained metabolic acidosis, and discussion
regarding antibiotic choice was not within
the scope of the article.
Further, the patient’s management before
admission to the intensive care unit was by a
different treating team. Subsequent case-
note review did not reveal reasons for initia-
tion or choice of antibiotics other than
described in our article, although it was
evident that gentamicin doses were adjusted
based on drug levels. We agree that a less
nephrotoxic agent could have been chosen
and that the profligate use of antibiotics in
the absence of strong evidence of infection
could have been avoided.
The excessive use of antibiotics in the
current medical milieu may stem from a
physician’s lack of confidence, or even legal
ramifications of “watching and waiting” in
the setting of “fevers, chills, rigors, raised
inflammatory markers and neutrophilia”, as
encountered in our patient.
John V Peter, Reader1
Natasha Rogers, Registrar, Renal Medicine2
Sandra L Peake, Intensive Care Physician2158 MJA • Volume 186 Number 3 • 5 February 2007
LETTERS1 Medical Intensive Care Unit, Christian Medical 
College and Hospital, Vellore, Tamil Nadu, 
India.
2 The Queen Elizabeth Hospital, Adelaide, SA.
peterjohnvictor@yahoo.com.au
1 Peter JV, Rogers N, Murty S, et al. An unusual cause
of severe metabolic acidosis. Med J Aust 2006; 185:
223-225. ❏
Performance indicators of 
a primary care skin cancer 
clinic network
Deborah A Askew, David Wilkinson 
and Gordon L Patrick
TO THE EDITOR: Primary care skin cancer
clinics continue to receive negative publicity.
We have previously reported on the workload
profile of one network of clinics.1 We report
here the profile of clinical activity of the four
MoleScan skin cancer clinics situated on the
Sunshine Coast, Queensland. Between them,
these clinics have been open for a total of 22
years, ranging from 2 years to nearly 9 years of
operation.
MoleScan is a service company with clinics
across Australia. Doctors are employed as sub-
contractors and are provided with digital der-
mascopes. The clinics do not have dedicated
day surgery facilities, and surgical procedures
are conducted in the consulting rooms (http://
www.molescan.com.au).
Using Medicare Benefits Schedule item
number billing data (as previously reported1),
we calculated the number of consultations,
biopsies, excised lesions (benign, non-
melanoma skin cancers [NMSCs] and
melanoma), surgical repairs, non-surgical
treatment of skin cancers, and non-surgical
treatment of other skin lesions. We also esti-
mated the number needed to treat (NNT),
defined as the number of benign lesions
removed per melanoma.
There were 98276 consultations at the four
clinics during the 22 years of operation (Box).
In all, 14982 skin cancers were treated: 395
melanomas and 7468 NMSCs by surgical exci-
sion, and 7119 NMSCs by non-surgical meth-
ods. The estimated NNT was 22.5.
Of the 16 962 lesions excised, 11% (1812)
were repaired by a skin flap, 68% (1226) of
which were simple flaps. Our previous
report, on a different network of clinics,1
showed a different pattern of surgical repairs:
33% (2651) of the 8055 lesions excised were
repaired by a skin flap, 45% (1187) of which
were simple flaps. Clearly, the clinical prac-
tices of these two clinic networks vary.
Another area of apparent difference
between the two clinic groups is the NNT —
22.5 reported here, compared with 28.6 from
the other network.1 The lower NNT in these
MoleScan clinics may result from the use of
digital dermoscopy, but this requires further
study.
These early findings from our analyses of
MoleScan data highlight the dangers of gen-
eralising about the activities of primary care
skin cancer clinics from one dataset. Work-
load profiles of different clinical services may
vary markedly, and the widely expressed
concern about large numbers of inappropri-
ate surgical repairs may not be warranted.
Competing interests: Gordon Patrick is the
founder and a director of MoleScan. He is also a
practising clinician working in a MoleScan clinic.
MoleScan made the data available for our study
with no restriction on the analysis undertaken. The
company viewed this letter for accuracy prior to
submission, but had no influence on the data
presented or their interpretation.
Deborah A Askew, Postdoctoral Research 
Fellow1
David Wilkinson, Professor of Primary Care and 
Head1
Gordon L Patrick, Director2
1 School of Medicine, University of Queensland, 
Brisbane, QLD.
2 MoleScan Skin Cancer Clinics, QLD.
d.askew@uq.edu.au
1 Wilkinson D, Askew DA, Dixon A. Skin cancer clinics
in Australia: workload profile and performance indi-
cators from an analysis of billing data. Med J Aust
2006; 184: 162-164. ❏
The psychosocial impact of 
prostate cancer on patients 
and their partners
James A Smith, Shaun M Filiault, 
Murray J Drummond and 
Robert J Knapman
TO THE EDITOR: We read with interest the
article by Couper et al on the psychosocial
impact of prostate cancer (PCA) on patients
and their female partners.1 We agree that
involvement of partners in the research pro-
cess is pivotal to understanding the relational
dimension of how PCA is both understood
and approached by men and their partners.2
However, this could be extended to con-
sider the unique experiences of gay men
diagnosed with PCA and their partners. Het-
eronormative viewpoints are commonplace
in PCA research. This bias is unfortunate, as
there is a 28% possibility that one of the men
Activities billed at four MoleScan skin cancer clinics on the Sunshine Coast, Queensland, over a total of 22 years of operation
* Eyelid, nose, ear, lip, neck, hand, digit or genitals. ◆
Billed activities n = 169 775
Consultations 
n = 98 276 (58%)
Biopsies 
n = 7458 (4%)
Lesions (benign and 
malignant) removed surgically 
n = 16 962 (10%)
Additional 
surgical repairs 
n = 1853 (1%)
Non-surgical treatments 
of cancers 
n = 7119 (4%)
Other treatments of pre-malignant
or non-malignant lesions 
n = 38 107 (22%)
Non-malignant lesions (mainly steroid 
injections of keloids and incision and 
drainage of abscesses) 
n = 10 050 (26%)
Pre-malignant lesions (mainly
cryotherapy of actinic keratoses) 
n = 28 057 (74%)
Short or long 
n = 20 502 (21%)
Standard 
n = 77 774 (79%)
Ellipse with direct suture repair 
n = 15 109 (89%)
Flap repair 




n = 41 (0.2%)
Site-speciﬁc ﬂap* 
n = 336 (19%)
Complicated ﬂap 
n = 250 (14%)
Simple ﬂap 
n = 1226 (68%)MJA • Volume 186 Number 3 • 5 February 2007 159
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in a gay relationship will develop PCA over
the course of his lifetime.3
While it is probable that gay men and their
partners have some of the same concerns
regarding PCA as heterosexual couples, there
are also unique concerns that are specific to
gay men and their partners. Such considera-
tions may include (but are not limited to):
• the prostate gland as a site of sexual
pleasure and the associated implications of
being able to engage in penetrative anal sex
after prostate surgery;4
• homophobia and/or disregard for sexual-
ity within the health care system5 when being
diagnosed with and treated for PCA; and
• the impact of polygamous (open) relation-
ships and the ambiguous position of gay
partners having to care for their mates.4
At this stage, the above concerns are purely
speculative, as there is a paucity of literature
on gay men and PCA.4,6 We believe future
research on the psychosocial impacts of PCA
should consider the experiences and special
concerns of gay men with PCA, as well as
those of their partners.
James A Smith, Health Promotion Officer1 and 
Doctoral Candidate2
Shaun M Filiault, Doctoral Candidate3
Murray J Drummond, Senior Lecturer3
Robert J Knapman, Community Development 
Officer4
1 Royal Adelaide Hospital, Adelaide, SA.
2 Discipline of Public Health, University of 
Adelaide, Adelaide, SA.
3 Division of Health Sciences, University of 
South Australia, Adelaide, SA.
4 Gay Men's Health, AIDS Council of South 
Australia, Adelaide, SA.
filiault@alum.bu.edu
1 Couper JW, Bloch S, Love A, et al. The psychosocial
impact of prostate cancer on patients and their
partners. Med J Aust 2006; 185: 428-432. 
2 Couper J, Bloch S, Love A, et al. Psychosocial
adjustment of female partners of men with prostate
cancer: a review of the literature. Psychooncology
2006; 15: 937-953.
3 Santillo VM, Lowe FC. Prostate cancer and the gay
male. In: Perlman G, Drescher J, editors. A gay
man’s guide to prostate cancer. Binghamton, NY:
Haworth Press, 2005: 9-27.
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Jeremy W Couper
IN REPLY: We thank Smith et al for their
acknowledgement of the importance of the
relational dimension to understanding how
prostate cancer (PCA) is understood and
approached by men and their partners. The
psychosocial implications of prostate cancer
for same-sex couples are important and
need specific investigation.
However, there are methodological diffi-
culties in attempting to quantify the impact
of PCA on same-sex couples and in compar-
ing their experience with other couples. In
our review of the literature,1 we discovered
that where previous researchers had
included same-sex partners in their studies,
insufficient numbers were recruited for
meaningful quantitative statistical compari-
sons. For example, Perez and colleagues,2
Neese and colleagues3 and Davison and
colleagues4 each recruited only one same-
sex couple into their studies of 134, 164 and
74 couples, respectively.
We believe that a qualitative approach is
needed, specifically seeking out and exam-
ining the experiences of a group of same-sex
couples and comparing and contrasting
their experiences with those of a group of
male–female couples. This is an approach
we are considering in future studies to help
us develop and refine an effective but
broadly applicable couple-focused psycho-
social intervention for PCA.
Jeremy W Couper, Lecturer
Department of Psychiatry, The University of 
Melbourne, Melbourne, VIC.
couperjw@svhm.org.au
1 Couper J, Bloch S, Love A, et al. Psychosocial
adjustment of female partners of men with prostate
cancer: a review of the literature. Psychooncology
2006; 15: 937-953.
2 Perez M, Skinner E, Meyerowitz B. Sexuality and
intimacy following radical prostatectomy: patient
and partner perspectives. Health Psychol 2002; 21:
288-293.
3 Neese L, Schover L, Klein E, et al. Finding help for
sexual problems after prostate cancer treatment: a
phone survey of men’s and women’s perspectives.
Psychooncology 2003; 12: 463-473.
4 Davison B, Gleave M, Goldenberg S, et al. Assess-
ing information and decision preferences of men
with prostate cancer and their partners. Cancer
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